Список литературы

31. Newman R.B., Goldenberg R.L., Iams J.D., Meis P.J., Mercer B.M., Moawad A.H. et al. Preterm prediction study: comparison of the cervical score and Bishop score for prediction of spontaneous preterm delivery. Obstet Gynecol. 2008; 112(3): 508–15.

32. Alfrevic Z., Allen-Coward H., Molina F., Vinuesa C.P., Nicolaides K. Targeted therapy for threatened preterm labor based on sonographic measurement of the cervical length: a randomized controlled trial. Ultrasound Obstet Gynecol. 2007; 29(1): 47–50.

33. Berghella V., Palacio M., Ness A., Alfrevic Z., Nicolaides K.H., Saccone G. Cervical length screening for prevention of preterm birth in singleton pregnancy with threatened preterm labor: systematic review and meta-analysis of randomized controlled trials using individual patient-level data. Ultrasound Obstet Gynecol. 2017; 49(3): 322–9.

34. Приказ Минздрава РФ от 20.10.2020 г. № 1130н «Об утверждении Порядка оказания медицинской помощи по профилю «акушерство и гинекология» http://sudact.ru/law/prikaz-minzdrava-rossii-ot-20102020-n-1130n/prilozhenie-n-1/.

35. Norman J.E., Marlow N., Messow C.-M., Shennan A., Bennett P.R., Thornton S. et al. Does progesterone prophylaxis to prevent preterm labour improve outcome? A randomised double blind placebo-controlled trial (OPPTIMUM). Health Technol Assess. 2018; 22(35): 1–304.

36. Medley N., Poljak B., Mammarella S., Alfrevic Z. Clinical guidelines for prevention and management of preterm birth: a systematic review. BJOG. 2018; 125(11): 1361–9.

37. Ting H.-S., Chin P.-S., Yeo G.S.H., Kwek K. Comparison of bedside test kits for prediction of preterm delivery: phosphorylated insulin-like growth factor binding protein-1 (pIGFBP-1) test and fetal fibronectin test. Ann Acad Med Singapore. 2007; 36(6): 399–402.

38. Сorabian P. The ACTIM PARTUS versus THE TLIIQ ® SYSTEM as rapid response tests to aid in diagnosing preterm labour in symptomatic women. In: Institute of Health Economics, Canada. 2008.

39. Fuchs F., Houllier M., Leparco, Guyot A., Senat M.V., Fernandez H. Performance of cervical phIGFBP-1 test alone or combined with short cervical length to predict spontaneous preterm birth in symptomatic women. Sci. Rep. 2017; 7(1): 10856.

40. Khambay H., Bolt L.A., Chandiramani M., De Greeff A., Filmer J.E., Shennan A.H. The Actim Partus test to predict pre-term birth in asymptomatic high-risk women. J. Obstet. Gynaecol. 2012; 32(2): 132–4.

41. Petrunin D.D., Gryaznova I.M., Petrunina Y.A. et al. Comparative immunochemical and physicochemical characteristics of chronicα1 and α2-microglobulins of the human placenta. Bull. Exp. Biol. Med. 1978. 85, doi: 10.1007/BF00806400.

42. Fuchs B.B., Boltovskaya M.N., Zaraiskii E.I., Nazimova S.V. Monoclonal antibodies against placental alpha-1-microglobulin (PAMG-1) International Journal of Immunopharmacology. 1991. 13(6), 793.

43. Sukchaya K., Phupong V. Comparative study of positive rate of placental alpha-microglobulin-1 test in pre-term pregnant women with and without uterine contraction. Journal of Obstetrics and Gynaecology. 2013. 33, 566–568. DOI: 10.3109/01443615.2013.807786.

44. Saul W. Rosen. New placental proteins: Chemistry, physiology and clinical use. Placenta. 1986. 7(6), 575–594.

45. Lee S.M., Romero R., Park J.W. et al. The clinical significance of a positive Amnisure test (TM) in women with preterm labour and intact membranes. J. Matern. Fetal Neonatal Med. 2012. 25 (9): 1690–1698.

46. Фаткуллин И.Ф., Ахметгалиев А.Р., Мунавирова А.А., Фаткуллин Ф.И. Преимущества применения диагностической экспресс-тест-системы для определения плацентарного α-микроглобулина-1 в цервикальном содержимом для идентификации начавшихся/угрожающих преждевременных родов // Акушерство и гинекология. 2018; 1: 62–8. https://dx.doi.org/10.18565/aig.2018.1.62-68.

47. Lotfi G., Faraz S., Nasir R., Somini S., Abdeldayem R.M., Koratkar R. et al. Comparison of the effectiveness of a PAMG-1 test and standard clinical assessment in the prediction of preterm birth and reduction of unnecessary hospital admissions. J. Matern. Fetal Neonatal Med. 2017; October 26: 1–5.

48. Melchor J.C., Navas H., Marcos M., Iza A., de Diego M., Rando D. et al. Retrospective cohort study of PAMG-1 and fetal fibronectin test performance in assessing spontaneous preterm birth risk in symptomatic women attending an emergency obstetrical unit. Ultrasound Obstet. Gynecol. 2017; Aug 29. Available at: https://www.ncbi.nlm.nih.gov.

49. Hadzi-Lega M., Maier J.T., Helmer H., Hellmeyer L., Markova A.D., Poposka A. Comparison of PAMG-1 and phIGFBP-1 tests for the prediction of preterm delivery in patients with preterm labor. Open J. Obstet. Gynecol. 2017; 7(3): 358–68.

50. Ravi M., Beljorie M., El Masry K. Evaluation of the quantitative fetal fibronectin test and PAMG-1 test for the prediction of spontaneous preterm birth in patients with signs and symptoms suggestive of preterm labor. J. Matern. Fetal Neonatal Med. 2018; May 28: 1–6.

51. Melchor J.C., Khalil A., Wing D., Schleussner E., Surbek D. Prediction of preterm delivery in symptomatic women using placental alpha-microglobulin-1, fetal fibronectin and phosphorylated insulin-like growth factor-binding protein-1 tests: systematic review and meta-analysis stratified by risk. Ultrasound Obstet. Gynecol. 2018; Jun 19. DOI: 10.1002/uog.19119.

52. Di Fabrizio L., Giardina I., Cetin I., Di Tommaso M., Ciavattini A., Locci M. et al. New methods for prediction of preterm birth: the PAMG-1 test. Minerva Ginecol. 2018; May 31. DOI: 10.23736/S0026-4784.18.04243-0.

53. Ehsanipoor R.M., Swank M.L., Jwa S.C., Wing D.A., Tarabulsi G., Blakemore K.J. Placental α-Microglobulin-1 in Vaginal Secretions of Women with Evidence of Preterm Labor. Am J Perinatol. 2016; 33(2): 208–13.

54. Kuhrt K., Watson H., Seed P., Shennan A. et al. Placental Alpha Microglobulin-1 Compared With Fetal Fibronectin to Predict Preterm Delivery in Symptomatic Women. Obstet Gynecol. 2018; 131: 743.

55. Fuchs F., Lefevre C., Senat M.-V., Fernandez H. Accuracy of fetal fbronectin for the prediction of preterm birth in symptomatic twin pregnancies: a pilot study https://doi.org/10.1038/s41598-018-20447-5.

56. Berghella V., Saccone G. Fetal fibronectin testing for prevention of preterm birth in singleton pregnancies with threatened preterm labor: a systematic review and meta-analysis of randomized controlled trials. Am. J. Obstet. Gynecol. 2016; 215(4): 431–8.

57. Ruma M.S., Bittner K.C., Soh C.B. Current perspectives on the use of fetal fibronectin testing in preterm labor diagnosis and management. Am. J. Manag. Care. 2017; 23(Suppl. 19): S356–62.

58. Care of Women Presenting with Suspected Preterm Prelabour Rupture of Membranes from 24+0 Weeks of Gestation: Green-top Guideline № 73, 2019.

59. Bianchi-Jassir F., Seale A.C., Kohli-Lynch M., Lawn J.E., Baker C.J., Bartlett L. et al. Preterm Birth Associated With Group B Streptococcus Maternal Colonization Worldwide: Systematic Review and Meta-analyses. Clin Infect Dis. 2017; 65(suppl 2): S133–42.

60. Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion Summary, Number 782. Obstet Gynecol. 2019; 134: 206–210.

61. Alfirevic Z., Stampalija T., Medley N. Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy. Cochrane database Syst Rev. 2017; 6: CD008991.

62. Ehsanipoor R.M., Seligman N.S., Saccone G., Szymanski L.M., Wissinger C., Werner E.F. et al. Physical Examination-Indicated Cerclage: A Systematic Review and Meta-analysis. Obstet Gynecol. 2015; 126(1): 125–35.

63. Преждевременные роды. Клинические рекомендации Минздрава РФ, 2020. https://minzdrav.samregion.ru/wp-content/uploads/sites/28/2020/12/prezhdevremennye-rody.pdf.

64. Айламазян Э.К. Акушерство и гинекология в статьях, выступлениях и лекциях. СПб.: Левша. Санкт-Петербург, 2014. 401 с.

65. Obstetric Care Consensus № 3: Periviable Birth, ACOG, 2015.

66. Vogel J.P., Nardin J.M., Dowswell T., West H.M., Oladapo O.T. Combination of tocolytic agents for inhibiting preterm labour. Cochrane database Syst Rev. 2014; 11;(7): CD0(7): CD006169.

67. Han S., Crowther C.A., Moore V. Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour. In: Crowther CA, editor. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd; 201072.

68. Haas D.M., Caldwell D.M., Kirkpatrick P., McIntosh J.J., Welton N.J. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ. 2012; 345: e6226.

69. Flenady V., Wojcieszek A.M., Papatsonis D.N.M., Stock O.M., Murray L., Jardine L.A. et al. Calcium channel blockers for inhibiting preterm labour and birth. Cochrane database Syst Rev. 2014;(6): CD002255.

70. Flenady V., Reinebrant H.E., Liley H.G., Tambimuttu E.G., Papatsonis D.N.M. Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane database Syst Rev. 2014; (6): CD004452.

71. Neilson J.P., West H.M., Dowswell T. Betamimetics for inhibiting preterm labour. Cochrane database Syst Rev. 2014;(2): CD004352.

72. ACOG Committee on Practice Bulletins. Practice Bulletin № 171: Management of Preterm Labor. Obstetrics & Gynecology. 2016; 128 (4): p.e155-e164. doi: 10.1097/aog.0000000000001711.

73. King J., Flenady V., Cole S., Thornton S. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane database Syst Rev. 2005; 18;(2): CD0(2): CD001992.

74. Gomez-Lopez N., Romero R., Panaitescu B., Leng Y., Xu Y., Tarca A.L. et al. Inflammasome activation during spontaneous preterm labor with intra-amniotic infection or sterile intra-amniotic inflammation. Am J Reprod Immunol. 2018; 80(5): e13049.

75. Costantine M.M., Weiner S.J., Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis. Obstet Gynecol. 2009; 114(2 Pt 1): 354–64.

76. Wolf H.T., Hegaard H.K., Greisen G., Huusom L., Hedegaard M. Treatment with magnesium sulphate in pre-term birth: a systematic review and meta-analysis of observational studies. J Obstet Gynaecol. 2012; 32: 135–40.

77. Clément Chollat, Lise Le Doussal, Gaëlle de la Villéon, Delphine Provost & Stéphane Marret. Antenatal magnesium sulphate administration for fetal neuroprotection: a French national survey. BMC Pregnancy and Childbirthvolume17, Article number: 304 (2017).

78. Doyle L.W., Crowther C.A., Middleton P., Marret S., Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev. 2009;(1): CD004661.